Table 2 |
||||
|
Summary of indicators for HIV Testing at first presentation |
||||
|
All n = 165 |
1995-2000 n = 48 |
2004-2009 n = 117 |
P value |
|
|
|
||||
|
Summary |
||||
|
Median no. clinical indicators |
1 (0-2) |
1 (1-2) |
1 (0-1) |
0.002 |
|
Median number of all non-clinical indicators |
2 (1-2) |
1 (1-2) |
2 (1-3) |
< 0.001 |
|
Median number of all clinical & non-clinical indicators |
3 (2-4) |
3 (2-4) |
3 (2-4) |
0.697 |
|
Services indicator (any) |
102 (62%) |
19 (40%) |
83 (71%) |
< 0.001 |
|
Ante-natal/ToP |
14 (9%) |
4 (8%) |
10 (9%) |
0.964 |
|
GUM |
61 (37%) |
8 (17%) |
53 (45%) |
0.001 |
|
TB, Hep B/C, lymphoma |
27 (16%) |
8 (17%) |
19 (16%) |
0.964 |
|
Occupational health or screening* |
11 (7%) |
3 (6%) |
8 (7%) |
0.891 |
|
Transmission risk indicator (any) |
132 (80%) |
33 (69%) |
99 (85%) |
0.021 |
|
Country of origin high prevalence (> 1%) |
53 (32%) |
10 (21%) |
43 (37%) |
0.047 |
|
Men with disclosed sexual contact with men (MSM) |
46 (28%) |
14 (29%) |
32 (27%) |
0.813 |
|
IVDU |
8 (5%) |
2 (4%) |
6 (5%) |
0.794 |
|
Sexual contact abroad |
42 (26%) |
10 (21%) |
32 (28%) |
0.383 |
|
Partner HIV+ |
24 (15%) |
6 (13%) |
18 (15%) |
0.633 |
|
Blood donors, dialysis patients or organ donors/recipients |
6 (4%) |
4 (8%) |
2 (2%) |
0.039 |
|
Non-clinical indicator (any transmission risk or service indicator) |
147 (89%) |
37 (77%) |
110 (94%) |
0.002 |
|
Clinical Indicator diseases (any) |
119 (72%) |
42 (88%) |
74 (63%) |
0.005 |
|
|
||||
|
Indicators as recommended by national guidelines for HIV testing, except *. |
||||
|
Wohlgemut et al. BMC Infectious Diseases 2012 12:72 doi:10.1186/1471-2334-12-72 |
||||
